ERLANGER BEHAVIORAL HEALTH — History
CCN 444026 | 3-year financial timeline | COVID resilience: 80/100
🛡️ Public data only — no PHI permitted on this instance.
$27M
Latest Revenue (FY2022)
+14.4%
Revenue CAGR (3yr)
15.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $20M | $25M | $27M | +7.8% | +14.4% |
| Operating Expenses | $18M | $21M | $23M | +6.7% | +11.4% |
| Operating Margin | 10.5% | 14.2% | 15.1% | +6.6% | +19.8% |
| Net Income | $2M | $3M | $4M | +14.9% | +37.1% |
| Licensed Beds | 88 | 88 | 96 | +9.1% | +4.4% |
| Total Patient Days | 25,079 | 28,899 | 28,794 | -0.4% | +7.2% |
| Medicare Day % | 18% | 13% | 12% | -6.8% | -17.6% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 80/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +30.8% ($20M → $27M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+14.4%
This Hospital
+7.6%
State Avg
Latest Margin
15.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $30M | 17.4% |
| FY2024 (proj) | $33M | 19.7% |
| FY2025 (proj) | $36M | 22.0% |